nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0667	0.0726	CbGbCtD
Glyburide—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0653	0.0711	CbGbCtD
Glyburide—SLCO1A2—Prednisone—ankylosing spondylitis	0.063	0.0686	CbGbCtD
Glyburide—ABCB11—Dexamethasone—ankylosing spondylitis	0.062	0.0675	CbGbCtD
Glyburide—ABCG2—Sulfasalazine—ankylosing spondylitis	0.059	0.0643	CbGbCtD
Glyburide—ABCC3—Methotrexate—ankylosing spondylitis	0.0576	0.0628	CbGbCtD
Glyburide—SLC22A7—Methotrexate—ankylosing spondylitis	0.0451	0.0491	CbGbCtD
Glyburide—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0393	0.0428	CbGbCtD
Glyburide—ABCC1—Methotrexate—ankylosing spondylitis	0.0354	0.0385	CbGbCtD
Glyburide—ABCC2—Dexamethasone—ankylosing spondylitis	0.0326	0.0355	CbGbCtD
Glyburide—ALB—Prednisone—ankylosing spondylitis	0.0325	0.0354	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0316	0.0344	CbGbCtD
Glyburide—ABCG2—Dexamethasone—ankylosing spondylitis	0.0295	0.0321	CbGbCtD
Glyburide—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0281	0.0306	CbGbCtD
Glyburide—ABCC2—Methotrexate—ankylosing spondylitis	0.0262	0.0285	CbGbCtD
Glyburide—ABCG2—Methotrexate—ankylosing spondylitis	0.0237	0.0258	CbGbCtD
Glyburide—CYP2C19—Prednisone—ankylosing spondylitis	0.0211	0.023	CbGbCtD
Glyburide—SLC22A6—Methotrexate—ankylosing spondylitis	0.0192	0.0209	CbGbCtD
Glyburide—ABCB1—Betamethasone—ankylosing spondylitis	0.0183	0.0199	CbGbCtD
Glyburide—ABCB1—Prednisolone—ankylosing spondylitis	0.018	0.0196	CbGbCtD
Glyburide—ABCB1—Prednisone—ankylosing spondylitis	0.017	0.0185	CbGbCtD
Glyburide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0168	0.0183	CbGbCtD
Glyburide—ALB—Methotrexate—ankylosing spondylitis	0.0163	0.0178	CbGbCtD
Glyburide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0132	0.0143	CbGbCtD
Glyburide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0128	0.0139	CbGbCtD
Glyburide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0109	0.0119	CbGbCtD
Glyburide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0109	0.0119	CbGbCtD
Glyburide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0108	0.0118	CbGbCtD
Glyburide—ABCB1—Dexamethasone—ankylosing spondylitis	0.0106	0.0116	CbGbCtD
Glyburide—CYP3A4—Prednisone—ankylosing spondylitis	0.0102	0.0111	CbGbCtD
Glyburide—Hypopituitarism—Methylprednisolone—ankylosing spondylitis	0.00881	0.108	CcSEcCtD
Glyburide—ABCB1—Methotrexate—ankylosing spondylitis	0.00854	0.0093	CbGbCtD
Glyburide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00636	0.00693	CbGbCtD
Glyburide—Allergic cutaneous angiitis—Methotrexate—ankylosing spondylitis	0.00153	0.0187	CcSEcCtD
Glyburide—Reaction gastrointestinal—Methotrexate—ankylosing spondylitis	0.00146	0.0178	CcSEcCtD
Glyburide—Blindness—Triamcinolone—ankylosing spondylitis	0.00133	0.0162	CcSEcCtD
Glyburide—Blindness—Methylprednisolone—ankylosing spondylitis	0.00133	0.0162	CcSEcCtD
Glyburide—Blindness—Dexamethasone—ankylosing spondylitis	0.00121	0.0147	CcSEcCtD
Glyburide—Blindness—Betamethasone—ankylosing spondylitis	0.00121	0.0147	CcSEcCtD
Glyburide—Nephropathy—Methotrexate—ankylosing spondylitis	0.00102	0.0125	CcSEcCtD
Glyburide—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.000991	0.0121	CcSEcCtD
Glyburide—Vasculitis—Prednisolone—ankylosing spondylitis	0.00082	0.01	CcSEcCtD
Glyburide—Eruption—Methotrexate—ankylosing spondylitis	0.00079	0.00965	CcSEcCtD
Glyburide—Encephalopathy—Methotrexate—ankylosing spondylitis	0.000757	0.00924	CcSEcCtD
Glyburide—Vasculitis—Triamcinolone—ankylosing spondylitis	0.000754	0.00921	CcSEcCtD
Glyburide—Vasculitis—Methylprednisolone—ankylosing spondylitis	0.000753	0.00919	CcSEcCtD
Glyburide—Vasculitis—Dexamethasone—ankylosing spondylitis	0.000684	0.00835	CcSEcCtD
Glyburide—Vasculitis—Betamethasone—ankylosing spondylitis	0.000684	0.00835	CcSEcCtD
Glyburide—Visual disturbance—Prednisolone—ankylosing spondylitis	0.000613	0.00748	CcSEcCtD
Glyburide—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.000608	0.00742	CcSEcCtD
Glyburide—Vascular purpura—Triamcinolone—ankylosing spondylitis	0.000597	0.00729	CcSEcCtD
Glyburide—Vasculitis—Prednisone—ankylosing spondylitis	0.000596	0.00727	CcSEcCtD
Glyburide—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.000559	0.00682	CcSEcCtD
Glyburide—Purpura—Triamcinolone—ankylosing spondylitis	0.000554	0.00677	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.000535	0.00653	CcSEcCtD
Glyburide—Visual disturbance—Betamethasone—ankylosing spondylitis	0.000512	0.00625	CcSEcCtD
Glyburide—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.000512	0.00625	CcSEcCtD
Glyburide—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.000507	0.00619	CcSEcCtD
Glyburide—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.000507	0.00619	CcSEcCtD
Glyburide—Abdominal distension—Prednisolone—ankylosing spondylitis	0.000506	0.00617	CcSEcCtD
Glyburide—Vasculitis—Methotrexate—ankylosing spondylitis	0.000498	0.00608	CcSEcCtD
Glyburide—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000492	0.00601	CcSEcCtD
Glyburide—Sweating increased—Prednisolone—ankylosing spondylitis	0.000489	0.00597	CcSEcCtD
Glyburide—Vascular purpura—Prednisone—ankylosing spondylitis	0.000472	0.00576	CcSEcCtD
Glyburide—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.000465	0.00568	CcSEcCtD
Glyburide—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.000464	0.00566	CcSEcCtD
Glyburide—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000456	0.00557	CcSEcCtD
Glyburide—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000453	0.00553	CcSEcCtD
Glyburide—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000452	0.00551	CcSEcCtD
Glyburide—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00045	0.00549	CcSEcCtD
Glyburide—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.000449	0.00548	CcSEcCtD
Glyburide—Purpura—Prednisone—ankylosing spondylitis	0.000438	0.00535	CcSEcCtD
Glyburide—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000408	0.00498	CcSEcCtD
Glyburide—Sweating increased—Betamethasone—ankylosing spondylitis	0.000408	0.00498	CcSEcCtD
Glyburide—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000393	0.00479	CcSEcCtD
Glyburide—Visual impairment—Prednisolone—ankylosing spondylitis	0.000387	0.00473	CcSEcCtD
Glyburide—Renal failure acute—Methotrexate—ankylosing spondylitis	0.000382	0.00467	CcSEcCtD
Glyburide—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000372	0.00455	CcSEcCtD
Glyburide—Abdominal distension—Prednisone—ankylosing spondylitis	0.000367	0.00448	CcSEcCtD
Glyburide—Pancreatitis—Prednisone—ankylosing spondylitis	0.000358	0.00437	CcSEcCtD
Glyburide—Sweating increased—Prednisone—ankylosing spondylitis	0.000356	0.00434	CcSEcCtD
Glyburide—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000355	0.00434	CcSEcCtD
Glyburide—Erythema—Prednisolone—ankylosing spondylitis	0.00035	0.00427	CcSEcCtD
Glyburide—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000345	0.00421	CcSEcCtD
Glyburide—Vision blurred—Prednisolone—ankylosing spondylitis	0.00033	0.00403	CcSEcCtD
Glyburide—Visual impairment—Betamethasone—ankylosing spondylitis	0.000323	0.00395	CcSEcCtD
Glyburide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000323	0.00395	CcSEcCtD
Glyburide—Erythema—Triamcinolone—ankylosing spondylitis	0.000322	0.00393	CcSEcCtD
Glyburide—Erythema—Methylprednisolone—ankylosing spondylitis	0.000321	0.00392	CcSEcCtD
Glyburide—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000321	0.00392	CcSEcCtD
Glyburide—Angioedema—Prednisolone—ankylosing spondylitis	0.00032	0.0039	CcSEcCtD
Glyburide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000313	0.00383	CcSEcCtD
Glyburide—Eye disorder—Betamethasone—ankylosing spondylitis	0.000313	0.00383	CcSEcCtD
Glyburide—Convulsion—Prednisolone—ankylosing spondylitis	0.000303	0.0037	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000302	0.00369	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000299	0.00365	CcSEcCtD
Glyburide—Alopecia—Dexamethasone—ankylosing spondylitis	0.000296	0.00362	CcSEcCtD
Glyburide—Alopecia—Betamethasone—ankylosing spondylitis	0.000296	0.00362	CcSEcCtD
Glyburide—Angioedema—Triamcinolone—ankylosing spondylitis	0.000294	0.00359	CcSEcCtD
Glyburide—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000293	0.00358	CcSEcCtD
Glyburide—Erythema—Betamethasone—ankylosing spondylitis	0.000292	0.00356	CcSEcCtD
Glyburide—Erythema—Dexamethasone—ankylosing spondylitis	0.000292	0.00356	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00029	0.00354	CcSEcCtD
Glyburide—Oedema—Prednisolone—ankylosing spondylitis	0.000286	0.00349	CcSEcCtD
Glyburide—Shock—Prednisolone—ankylosing spondylitis	0.000281	0.00343	CcSEcCtD
Glyburide—Convulsion—Triamcinolone—ankylosing spondylitis	0.000279	0.0034	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000278	0.0034	CcSEcCtD
Glyburide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000278	0.0034	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000276	0.00337	CcSEcCtD
Glyburide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000274	0.00334	CcSEcCtD
Glyburide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000273	0.00334	CcSEcCtD
Glyburide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000273	0.00334	CcSEcCtD
Glyburide—Eye disorder—Prednisone—ankylosing spondylitis	0.000273	0.00333	CcSEcCtD
Glyburide—Angioedema—Dexamethasone—ankylosing spondylitis	0.000267	0.00326	CcSEcCtD
Glyburide—Angioedema—Betamethasone—ankylosing spondylitis	0.000267	0.00326	CcSEcCtD
Glyburide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000264	0.00323	CcSEcCtD
Glyburide—Oedema—Triamcinolone—ankylosing spondylitis	0.000263	0.00321	CcSEcCtD
Glyburide—Shock—Triamcinolone—ankylosing spondylitis	0.000258	0.00315	CcSEcCtD
Glyburide—Alopecia—Prednisone—ankylosing spondylitis	0.000258	0.00315	CcSEcCtD
Glyburide—Shock—Methylprednisolone—ankylosing spondylitis	0.000258	0.00315	CcSEcCtD
Glyburide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000257	0.00314	CcSEcCtD
Glyburide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000256	0.00313	CcSEcCtD
Glyburide—Malnutrition—Prednisone—ankylosing spondylitis	0.000254	0.0031	CcSEcCtD
Glyburide—Erythema—Prednisone—ankylosing spondylitis	0.000254	0.0031	CcSEcCtD
Glyburide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000254	0.0031	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000254	0.0031	CcSEcCtD
Glyburide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000253	0.00309	CcSEcCtD
Glyburide—Convulsion—Betamethasone—ankylosing spondylitis	0.000253	0.00309	CcSEcCtD
Glyburide—Convulsion—Dexamethasone—ankylosing spondylitis	0.000253	0.00309	CcSEcCtD
Glyburide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000249	0.00303	CcSEcCtD
Glyburide—Myalgia—Betamethasone—ankylosing spondylitis	0.000249	0.00303	CcSEcCtD
Glyburide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000245	0.00299	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—ankylosing spondylitis	0.000244	0.00298	CcSEcCtD
Glyburide—Vision blurred—Prednisone—ankylosing spondylitis	0.00024	0.00293	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000239	0.00292	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000239	0.00291	CcSEcCtD
Glyburide—Oedema—Betamethasone—ankylosing spondylitis	0.000238	0.00291	CcSEcCtD
Glyburide—Oedema—Dexamethasone—ankylosing spondylitis	0.000238	0.00291	CcSEcCtD
Glyburide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000236	0.00288	CcSEcCtD
Glyburide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000235	0.00287	CcSEcCtD
Glyburide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000235	0.00287	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000235	0.00287	CcSEcCtD
Glyburide—Anaemia—Prednisone—ankylosing spondylitis	0.000235	0.00287	CcSEcCtD
Glyburide—Shock—Dexamethasone—ankylosing spondylitis	0.000234	0.00286	CcSEcCtD
Glyburide—Shock—Betamethasone—ankylosing spondylitis	0.000234	0.00286	CcSEcCtD
Glyburide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000234	0.00286	CcSEcCtD
Glyburide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000234	0.00285	CcSEcCtD
Glyburide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000234	0.00285	CcSEcCtD
Glyburide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000233	0.00285	CcSEcCtD
Glyburide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000233	0.00285	CcSEcCtD
Glyburide—Angioedema—Prednisone—ankylosing spondylitis	0.000232	0.00284	CcSEcCtD
Glyburide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000231	0.00282	CcSEcCtD
Glyburide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000231	0.00282	CcSEcCtD
Glyburide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00023	0.00281	CcSEcCtD
Glyburide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00023	0.00281	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000228	0.00278	CcSEcCtD
Glyburide—Anorexia—Betamethasone—ankylosing spondylitis	0.000227	0.00277	CcSEcCtD
Glyburide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000227	0.00277	CcSEcCtD
Glyburide—Urticaria—Prednisolone—ankylosing spondylitis	0.000227	0.00277	CcSEcCtD
Glyburide—Hypotension—Betamethasone—ankylosing spondylitis	0.000223	0.00272	CcSEcCtD
Glyburide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000223	0.00272	CcSEcCtD
Glyburide—Convulsion—Prednisone—ankylosing spondylitis	0.00022	0.00269	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000217	0.00265	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000217	0.00265	CcSEcCtD
Glyburide—Arthralgia—Prednisone—ankylosing spondylitis	0.000217	0.00264	CcSEcCtD
Glyburide—Myalgia—Prednisone—ankylosing spondylitis	0.000217	0.00264	CcSEcCtD
Glyburide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000216	0.00264	CcSEcCtD
Glyburide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000216	0.00264	CcSEcCtD
Glyburide—Alopecia—Methotrexate—ankylosing spondylitis	0.000216	0.00263	CcSEcCtD
Glyburide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000214	0.00262	CcSEcCtD
Glyburide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000214	0.00261	CcSEcCtD
Glyburide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000214	0.00261	CcSEcCtD
Glyburide—Erythema—Methotrexate—ankylosing spondylitis	0.000213	0.00259	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000213	0.00259	CcSEcCtD
Glyburide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00021	0.00257	CcSEcCtD
Glyburide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00021	0.00256	CcSEcCtD
Glyburide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00021	0.00256	CcSEcCtD
Glyburide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000209	0.00255	CcSEcCtD
Glyburide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000208	0.00254	CcSEcCtD
Glyburide—Oedema—Prednisone—ankylosing spondylitis	0.000208	0.00253	CcSEcCtD
Glyburide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000207	0.00253	CcSEcCtD
Glyburide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000207	0.00253	CcSEcCtD
Glyburide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000207	0.00253	CcSEcCtD
Glyburide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000206	0.00251	CcSEcCtD
Glyburide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000206	0.00251	CcSEcCtD
Glyburide—Shock—Prednisone—ankylosing spondylitis	0.000204	0.00249	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000204	0.00248	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000201	0.00245	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—ankylosing spondylitis	0.0002	0.00244	CcSEcCtD
Glyburide—Anorexia—Prednisone—ankylosing spondylitis	0.000198	0.00241	CcSEcCtD
Glyburide—Anaemia—Methotrexate—ankylosing spondylitis	0.000196	0.0024	CcSEcCtD
Glyburide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000196	0.0024	CcSEcCtD
Glyburide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000196	0.0024	CcSEcCtD
Glyburide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000195	0.00238	CcSEcCtD
Glyburide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000195	0.00238	CcSEcCtD
Glyburide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000194	0.00236	CcSEcCtD
Glyburide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000193	0.00236	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00019	0.00232	CcSEcCtD
Glyburide—Urticaria—Betamethasone—ankylosing spondylitis	0.000189	0.00231	CcSEcCtD
Glyburide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000189	0.00231	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000189	0.00231	CcSEcCtD
Glyburide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000188	0.0023	CcSEcCtD
Glyburide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000188	0.0023	CcSEcCtD
Glyburide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000188	0.0023	CcSEcCtD
Glyburide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000188	0.00229	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000186	0.00227	CcSEcCtD
Glyburide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000186	0.00227	CcSEcCtD
Glyburide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000185	0.00226	CcSEcCtD
Glyburide—Convulsion—Methotrexate—ankylosing spondylitis	0.000184	0.00225	CcSEcCtD
Glyburide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000183	0.00223	CcSEcCtD
Glyburide—Myalgia—Methotrexate—ankylosing spondylitis	0.000181	0.00221	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000181	0.00221	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00018	0.0022	CcSEcCtD
Glyburide—Rash—Prednisolone—ankylosing spondylitis	0.00018	0.0022	CcSEcCtD
Glyburide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00018	0.0022	CcSEcCtD
Glyburide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000179	0.00219	CcSEcCtD
Glyburide—Headache—Prednisolone—ankylosing spondylitis	0.000179	0.00218	CcSEcCtD
Glyburide—Confusional state—Methotrexate—ankylosing spondylitis	0.000175	0.00213	CcSEcCtD
Glyburide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000171	0.00209	CcSEcCtD
Glyburide—Asthenia—Betamethasone—ankylosing spondylitis	0.000171	0.00209	CcSEcCtD
Glyburide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000171	0.00209	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00017	0.00208	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00017	0.00207	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00017	0.00207	CcSEcCtD
Glyburide—Nausea—Prednisolone—ankylosing spondylitis	0.00017	0.00207	CcSEcCtD
Glyburide—Pruritus—Betamethasone—ankylosing spondylitis	0.000169	0.00206	CcSEcCtD
Glyburide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000169	0.00206	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000168	0.00205	CcSEcCtD
Glyburide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000167	0.00204	CcSEcCtD
Glyburide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000167	0.00203	CcSEcCtD
Glyburide—Rash—Triamcinolone—ankylosing spondylitis	0.000166	0.00202	CcSEcCtD
Glyburide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000165	0.00202	CcSEcCtD
Glyburide—Anorexia—Methotrexate—ankylosing spondylitis	0.000165	0.00202	CcSEcCtD
Glyburide—Rash—Methylprednisolone—ankylosing spondylitis	0.000165	0.00202	CcSEcCtD
Glyburide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000165	0.00201	CcSEcCtD
Glyburide—Urticaria—Prednisone—ankylosing spondylitis	0.000165	0.00201	CcSEcCtD
Glyburide—Headache—Triamcinolone—ankylosing spondylitis	0.000165	0.00201	CcSEcCtD
Glyburide—Headache—Methylprednisolone—ankylosing spondylitis	0.000164	0.002	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000164	0.002	CcSEcCtD
Glyburide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000163	0.00199	CcSEcCtD
Glyburide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000163	0.00199	CcSEcCtD
Glyburide—Hypotension—Methotrexate—ankylosing spondylitis	0.000162	0.00198	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000158	0.00193	CcSEcCtD
Glyburide—Nausea—Triamcinolone—ankylosing spondylitis	0.000156	0.0019	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000156	0.0019	CcSEcCtD
Glyburide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000156	0.0019	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000155	0.00189	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000153	0.00187	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000153	0.00186	CcSEcCtD
Glyburide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000152	0.00185	CcSEcCtD
Glyburide—Vomiting—Betamethasone—ankylosing spondylitis	0.000152	0.00185	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000151	0.00184	CcSEcCtD
Glyburide—Rash—Dexamethasone—ankylosing spondylitis	0.00015	0.00183	CcSEcCtD
Glyburide—Rash—Betamethasone—ankylosing spondylitis	0.00015	0.00183	CcSEcCtD
Glyburide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00015	0.00183	CcSEcCtD
Glyburide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00015	0.00183	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00015	0.00183	CcSEcCtD
Glyburide—Headache—Betamethasone—ankylosing spondylitis	0.000149	0.00182	CcSEcCtD
Glyburide—Headache—Dexamethasone—ankylosing spondylitis	0.000149	0.00182	CcSEcCtD
Glyburide—Asthenia—Prednisone—ankylosing spondylitis	0.000149	0.00182	CcSEcCtD
Glyburide—Pruritus—Prednisone—ankylosing spondylitis	0.000147	0.00179	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000143	0.00174	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000142	0.00173	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000142	0.00173	CcSEcCtD
Glyburide—Nausea—Dexamethasone—ankylosing spondylitis	0.000142	0.00173	CcSEcCtD
Glyburide—Nausea—Betamethasone—ankylosing spondylitis	0.000142	0.00173	CcSEcCtD
Glyburide—Urticaria—Methotrexate—ankylosing spondylitis	0.000138	0.00168	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000137	0.00167	CcSEcCtD
Glyburide—Vomiting—Prednisone—ankylosing spondylitis	0.000132	0.00161	CcSEcCtD
Glyburide—Rash—Prednisone—ankylosing spondylitis	0.000131	0.0016	CcSEcCtD
Glyburide—Dermatitis—Prednisone—ankylosing spondylitis	0.000131	0.0016	CcSEcCtD
Glyburide—Headache—Prednisone—ankylosing spondylitis	0.00013	0.00159	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000128	0.00156	CcSEcCtD
Glyburide—Asthenia—Methotrexate—ankylosing spondylitis	0.000124	0.00152	CcSEcCtD
Glyburide—Nausea—Prednisone—ankylosing spondylitis	0.000123	0.0015	CcSEcCtD
Glyburide—Pruritus—Methotrexate—ankylosing spondylitis	0.000123	0.0015	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000119	0.00145	CcSEcCtD
Glyburide—Vomiting—Methotrexate—ankylosing spondylitis	0.00011	0.00135	CcSEcCtD
Glyburide—Rash—Methotrexate—ankylosing spondylitis	0.000109	0.00133	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000109	0.00133	CcSEcCtD
Glyburide—Headache—Methotrexate—ankylosing spondylitis	0.000109	0.00133	CcSEcCtD
Glyburide—Nausea—Methotrexate—ankylosing spondylitis	0.000103	0.00126	CcSEcCtD
